Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Ticker SymbolGELS
Company nameGelteq Ltd
IPO dateOct 29, 2024
CEOMr. Nathan Jacob Givoni
Number of employees7
Security typeOrdinary Share
Fiscal year-endOct 29
AddressLevel 4
CityMELBOURNE
Stock exchangeNASDAQ Capital Market Consolidated
CountryAustralia
Postal code3205
Phone61390873990
Websitehttps://www.gelteq.com
Ticker SymbolGELS
IPO dateOct 29, 2024
CEOMr. Nathan Jacob Givoni
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data